CClinicalTrials.gg
TerminatedNCT07126210Updated Sep 16, 2026

Weight Management Program for Obese Preschool Children

An interventional study of Family engaged, enhanced Diet intervention in Childhood Obesity, sponsored by Peking University. Terminated at 1 site in China. Open to participants aged 4 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Peking University · Not applicable, Interventional, and Treatment

Why this study was terminated
Study terminated prematurely due to poor accrual. The actual number of eligible children recruited from kindergartens was far lower than expected, making the study unfeasible.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
4 Years to 6 Years
Sex
All
01

Study summary

The PKU-FeeD trial is a cluster-randomized controlled trial conducted in Jinan, Shandong Province, China. This study aims to: 1) Develop and evaluate a digital health-assisted, multidisciplinary intervention for preschool children with obesity, assessing its effectiveness and cost-effectiveness. 2) Investigate how lifestyle-based interventions influence the composition and function of the gut microbiota in obese preschoolers, and elucidate the mechanisms by which these interventions may modulate gut microbiota to affect obesity-related metabolic phenotypes.

Read the detailed description

Childhood obesity has become a global public health challenge, and early prevention and management are crucial to curbing its epidemic. However, compared to school-aged children, evidence on effective obesity interventions for preschoolers remains limited and inconsistent. While preventive approaches may have broader population-level implications, targeted management interventions may be more cost-effective in settings with lower obesity prevalence but rising trends, providing foundational evidence for future preventive strategies.

The gut microbiota plays a key role in host energy metabolism and metabolic homeostasis, and its dysbiosis is strongly linked to obesity. Diet and physical activity, as core components of lifestyle interventions, may significantly shape gut microbial ecology, potentially influencing host metabolism and obesity-related outcomes. However, due to challenges in sample collection, existing studies on gut microbiota in children are scarce, with small sample sizes, and few intervention studies have established causal relationships. The interplay between healthy lifestyle interventions, gut microbiota, and childhood obesity remains understudied, and the underlying mechanisms require further exploration. Thus, this trial seeks to: 1) determine effectiveness of a digital health-supported, comprehensive intervention for preschool obesity management. 2) Elucidate causal relationships between dietary behaviors, gut microbiota, and obesity in preschoolers.

02

Conditions studied

  • Childhood Obesity

Keywords

  • Obesity
  • Intervention
  • Preschool
  • Management
  • Children
03

In context

Pediatric Obesity

1,117 studies on the registry are indexed under Pediatric Obesity; 189 are open to participants now.

This study's enrollment of 25 is below the median of 103 across 862 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Peking University is the lead sponsor of 411 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The child's primary caregivers can proficiently use smart phones.
  • Child is expected to remain in the same kindergarten for at least one year.
  • No use of antibiotics or probiotic supplements, no acute stress events (e.g., trauma or severe infection), gastrointestinal symptoms (e.g., abdominal pain, constipation, diarrhea), or vaccinations within the 3 months prior to stool sample collection.
  • Parents voluntarily agree to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Obesity caused by genetic factors, diseases (e.g., endocrine disorders, central nervous system damage), or medication use.
  • History of major organ diseases, including cardiovascular, pulmonary, hepatic, or renal conditions (e.g., heart disease, hypertension, asthma).
  • Children following special diets (e.g., vegetarians).
  • Children with pathological eating disorders or medical conditions that limit physical activity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    multicomponent intervention

    This study adopts a multicomponent intervention based on the "3 Less, 2 More, 1 Team" approach-Less fried/fatty foods, less sugar, less overeating; More colorful foods, more physical activity; and One team (family working together to raise a healthy child). The intervention is family-centered, supported by kindergartens and hospitals, with digital health technology.

    Behavioral: Family engaged, enhanced Diet intervention

  • No intervention
    usual-care control

    In the control group, participating preschools will receive no intervention during the study period and will continue their routine educational and management practices without modification. After the study is fully completed, control group preschools will receive access to all intervention materials and health education resources developed for this project.

Interventions

  • BehavioralFamily engaged, enhanced Diet intervention

    The family component includes health education via books, lectures, and short videos, parenting skills training, regular monitoring of child growth, and behavior goal setting through the mobile health platform. Motivational interviewing via telephone provides tailored behavioral support. Kindergartens assist in health education, supervise dietary intake and physical activity, monitor children's growth monthly, and maintain communication with families. Hospitals provide targeted health counseling and facilitate clinic access as needed. The mobile health platform integrates modules for health education, smart growth curve tracking, behavior goal management, and home-school-hospital collaboration.

06

What researchers measure

Primary outcomes

  1. children's BMI-Z change

    Calculated based on height and weight using WHO standards. The primary outcome is the difference between two arms in the change of children's BMI-Z scores from baseline to the end of the intervention.

    Time frame: at end of the 9-month intervention

Secondary outcomes

  1. children's BMI-Z change

    Calculated based on height and weight using WHO standards. The primary outcome is the difference between two arms in the change of children's BMI-Z scores from baseline to follow-up.

    Time frame: at 21-month follow-up.

  2. Body Mass Index (BMI)

    BMI is calculated from measured height and weight.

    Time frame: at the end of the 9-month intervention; at 21-month follow-up.

  3. Waist Circumference

    Waist circumference is measured at the midpoint between the lower margin of the last palpable rib and the top of the iliac crest to evaluate central adiposity.

    Time frame: at the end of the 9-month intervention; at 21-month follow-up

  4. waist-to-Height Ratio, WHtR

    Calculated by dividing waist circumference by height, used as an indicator of fat distribution and risk for metabolic complications.

    Time frame: at the end of the 9-month intervention; at 21-month follow-up.

  5. Systolic and Diastolic Blood Pressures

    Blood pressure is measured using an electronic sphygmomanometer with the child seated after resting, to assess cardiovascular health.

    Time frame: at the end of the 9-month intervention; at 21-month follow-up.

  6. Body Composition

    Body fat percentage is assessed using a bioelectrical impedance analyzer (MC-780A, TANITA, Tokyo, Japan).

    Time frame: at the end of the 9-month intervention

  7. Prevalence and Incidence of Overweight/Obesity

    The proportion of children classified as overweight or obese according to WHO and Chinese standards, including newly identified cases at follow-up.

    Time frame: at the end of the 9-month intervention; at 21-month follow-up

  8. Dietary Intake

    Total energy intake, macronutrient distribution, and food group consumption will be assessed using three consecutive 24-hour dietary recalls. Changes in dietary quality and structure will be evaluated.

    Time frame: at the end of the 9-month intervention

  9. Children's Eating Behaviors

    Assessed using the Children's Eating Behavior Questionnaire (CEBQ), measuring dimensions such as food responsiveness, satiety responsiveness, and emotional eating

    Time frame: at the end of the 9-month intervention

  10. Parental Feeding Practices (CPCFBS)

    Measured using the Chinese Preschooler's Caregivers Feeding Behavior Scale (CPCFBS), evaluating dimensions such as monitoring, pressure to eat, and food restriction.

    Time frame: at the end of the 9-month intervention

  11. Time Spent in Physical Activity

    1)Children will wear an ActiGraph accelerometer for 7 consecutive days. Time spent in light, moderate, and vigorous physical activity will be calculated to evaluate changes in physical activity patterns. 2) Evaluated using the Children's Leisure Activities Study Survey (CLASS), assessing the amount and type of physical activity and sedentary behavior, including screen time.

    Time frame: at the end of the 9-month intervention

  12. Sedentary Behavior and Screen Time

    1)Children will wear an ActiGraph accelerometer for 7 consecutive days. Time spent in light, moderate, and vigorous physical activity will be calculated to evaluate changes in physical activity patterns. 2) Evaluated using the Children's Leisure Activities Study Survey (CLASS), assessing the amount and type of physical activity and sedentary behavior, including screen time.

    Time frame: at the end of the 9-month intervention

  13. Gut Microbial Composition

    Stool samples will be collected at baseline and post-intervention. Gut microbial composition is measured by 16S rRNA sequencing

    Time frame: at the end of the 9-month intervention

07

Study locations

1 site
  • Department of Maternal and Child Health, School of Public Health
    Beijing, Beijing Municipality 100191, China
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared publicly due to ethical considerations. In accordance with the study's ethical approval and informed consent procedures, the data contain potentially sensitive personal health information and are protected to ensure participant confidentiality and privacy. Data access is therefore restricted to authorized research personnel only and cannot be made publicly available.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07126210
Lead sponsor
Peking University
Collaborators
Shandong Maternal and Child Health Hospital
Responsible party
Hai-Jun Wang (Professor in Department of Maternal and Child Health, School of Public Health, Peking University, Peking University) — Principal investigator
First posted
Aug 17, 2025
Start date
Oct 1, 2025
Primary completion
Nov 30, 2025
Completion
Nov 30, 2025
Last update
Sep 16, 2026

Study contacts

Haijun Wang, PhD
principal investigator · Peking University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion